How Biopharmaceutical Science Is Fighting Back Against the Coronavirus

As people across the globe continue to be impacted by COVID-19, the disease caused by a new strain of coronavirus, biopharmaceutical companies have rapidly taken action to research and develop potential new medicines, while partnering with public health leaders worldwide, to combat this global public health emergency.

Improving Health Care Quality While Reducing Costs

The latest immunosuppressant therapies are transforming the lives of patients in ways beyond physical success. Innovations in treatment not only help extend life, they can also reduce health care costs to give back confidence and hope to patients for the future.

Protecting Breakthroughs

In recent years, rapid advances in scientific discovery have ushered in a new era of medicine.

0 of 0

TELL WASHINGTON TO PROTECT INNOVATION

The United States is in a new era of medical discovery that holds unlimited promise for potential medicines targeting complex conditions, like Alzheimer’s and cancer. Make your voice heard and tell Washington we do not need to put medical innovation in jeopardy.

GO BOLDLY

POPULAR ARTICLES

Can We Afford the New Era of Medicine?

Innovative treatments require innovative partnerships. America's Biopharmaceutical Companies and insurers are partnering to get the right medicine in the hands of patients who need them.

Researcher Profile: Jirong Lu

Dr. Jirong Lu, a distinguished research fellow at Eli Lilly and Company (Lilly), traces the beginnings of her career to a high school fascination with chemistry.

Policy Solutions to Push Progress Forward

We are in a new era of medical discovery and have the potential to revolutionize the treatment of costly and debilitating diseases. But we must not take this progress for granted.

The Greatest Gift of All: Hope

My son Parker's journey with juvenile arthritis (JA) began 10 years ago when he was in elementary school.

Migraine: More Than Just A Headache image

Migraine: More than Just a Bad Headache

Migraine is a debilitating neurological disease that is often misunderstood by those who do not suffer symptoms, according to the Migraine Impact Report, a new survey recently released by Eli Lilly and Company and conducted by Nielsen.

Washington is considering policy changes that could threaten innovation

New policy proposals in Washington threaten to hamstring investment in innovation and jeopardize breakthroughs.

Tackling Neurological Disorders in New Ways

Chronic pain. Alzheimer's disease. Multiple Sclerosis. Brain tumors. These are some of the most well-known and prevalent diseases afflicting the more than 100 million Americans who are impacted by a neurological disorder.

Together, we fight disease

0 of 0

Nothing is possible without innovation.

In Search of Targeted Treatments for Lupus

Ryan’s research gives Mitra hope that the limitations of her lupus will not last forever.

LEARN MORE

I am living proof that innovation is worth it

A Lifeline for Blood Cancer

The battle against blood cancer is one that can strike early, often beginning in childhood. But thanks to the unstoppable resolve of researchers, groundbreaking treatments can now harness the body's own cells to power the fight and help give back time to patients and their families.

LEARN MORE

I saw no limitations to what I could do

Pushing the boundaries of science to treat Parkinson’s disease

Biopharma researchers like Doug are fighting to give Parkinson's patients like Rich their normal lives back.

LEARN MORE

0 of 0

Diseases

Home Page

At the core of innovative research and development of lifesaving medicines is our single vision: a world without illness. And with a pipeline of promising new treatments, we're closer than ever to reaching our goal.

Autoimmune Diseases

Home Page

These diseases occur when the immune system attacks the body’s own tissues. Learn about advancements in the field.

Heart Diseases

Home Page

Heart disease is the leading cause of death in the U.S. Learn how researchers are making advances with the latest treatments.

Cancer

Home Page

Cancer is the second leading cause of death in the U.S., but death rates are declining. See how researchers are fighting back.

Treatment Approaches

Home Page

This is an age of promise – fueled by the drive to discover and a dedication to a future without illness. As researchers relentlessly pursue the next breakthrough, they put us closer than ever to take down disease.